Valeant Pharmaceuticals International has announced the acquisition of Aton Pharma, a specialty pharmaceutical company focused on ophthalmology and certain orphan drug indications, located in Lawrenceville, New Jersey.

Valeant raised $37m in funding from venture capitalists, including Aisling Capital, HealthCare Ventures and Johnson & Johnson Development Corp, for the buy.

The purchase of Aton follows a number of recent acquisitions by Valeant, including Brazil's Instituto Terapeutico Delta in March, and an unnamed Brazilian company and Canada's Vital Science Corp in April.

Comments

Search RSS

All rights reserved."